- Home
- PBYI vs OLP Comparison
PBYI vs OLP Comparison
Compare PBYI & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | OLP |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.1M | 471.5M |
| IPO Year | 2011 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PBYI | OLP |
|---|---|---|
| Price | $8.22 | $21.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.83 |
| AVG Volume (30 Days) | ★ 410.6K | 80.2K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 8.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.20 | ★ 1.04 |
| Revenue | $27,685,000.00 | ★ $82,740,000.00 |
| Revenue This Year | N/A | $10.43 |
| Revenue Next Year | $1.33 | $2.86 |
| P/E Ratio | $105.13 | ★ $20.63 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $4.76 | $19.86 |
| 52 Week High | $11.50 | $25.88 |
Technical Indicators
Market Signals| Indicator | PBYI | OLP |
|---|---|---|
| Relative Strength Index (RSI) | 30.69 | 38.49 |
| Support Level | $7.64 | N/A |
| Resistance Level | $8.53 | $23.54 |
| Average True Range (ATR) | 0.53 | 0.62 |
| MACD | -0.33 | -0.08 |
| Stochastic Oscillator | 14.61 | 25.95 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.